NCT00004327View on ClinicalTrials.gov

Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 31, 1995

Conditions
Hereditary Hemorrhagic TelangiectasiaEctasia
Interventions
DRUG

octreotide

All Listed Sponsors
collaborator

Yale University

OTHER

lead

National Center for Research Resources (NCRR)

NIH